The UK government has published a voluntary code of practice fororganizations that offer human genetic testing services direct to the public.
Public Health Minister Tessa Jowell said last week that the services will be monitored by a nonstatutory Advisory Committee on Genetic Testing, whose members include consumers, industry groups, clinicians, academics and scientists. In the coming months, it will also complete a research paper on late-onset genetic disorders and consider the issues surrounding preimplantation genetic diagnosis.
The panel's annual report will list those testing service proposals that comply with its code and those that do not, plus services which are still under review.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze